BioRestorative Therapies Inc (NASDAQ:BRTX) currently has a daily average trading volume of 384.57K but it saw 1446023 shares traded in last market. With a market cap of 11.21M USD, the company’s current market price of $1.62 came falling about -15.18 while comparing to the previous closing price of $1.91. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.55 and as low as $1.03.
Taking a look at 20-day trading activity of BioRestorative Therapies Inc (BRTX) gives us an average price of $2.1649, while its current price level is -36.47% below from 52-week high level whereas it is 57.28% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.9224 while that of 200 days or SMA-200 reads an average of $1.6711. A closer look into the stock’s movement over the week reveals that its volatility is standing at 23.85% during that period while stretching the period over a month that decreases to 13.07%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 37.64 which implies that the stock is in neutral territory.
Over the week, BRTX’s stock price is moving -17.35% down while it is -30.77% when we observe its performance for the past one month. Year-to-date it is 13.29% up and over the past year, the stock is showing an upside performance of 20.90%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of -0.27 while estimate for next year EPS is 0. In next quarter, company is expected to be making quarterly sales of $628k as analysts are expecting the sales for current fiscal year at $833k and seeing the company making $2.6M in sales next year. Moreover, analysts are in estimates of $475k for current-quarter revenue.
Currently, BioRestorative Therapies Inc’s total number of outstanding shares is 6.92M with 27.48% of that held by the insiders while 13.91% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -61.76% and return on equity (ROE) at -54.09%. Stock’s beta reads 63.69. Stock has a price to book (P/B) ratio of 1.12 while price to sale or P/S ratio amounts to 29.50. Its return on asset (ROA) is -43.49% on average.
